ArticleInternational journal of cosmetic science2025
Bioactivity and physicochemical characterization of Centella asiatica and Marigold extract serums: Antioxidant, anti-inflammatory, anti-tyrosinase and skin barrier function insights.
Article in International journal of cosmetic science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Trial
- Exploring the Cosmeceutical Potential of Six Malaysian Indigenous Tropical Fruit Trees: Radical Scavenging, Anti-Tyrosinase, and Photoprotective Activities Evaluation.Chemistry & biodiversity · 2026Article
- Engineering a Nanostructured Hybrid Gel System with Sodium Humate for Enhanced Wound Healing.Journal of functional biomaterials · 2026Article
- Bioactivity and physicochemical characterization of Centella asiatica and Marigold extract serums: Antioxidant, anti-inflammatory, anti-tyrosinase and skin barrier function insights.International journal of cosmetic science · 2025Article
- The Skin Microbiome and Bioactive Compounds: Mechanisms of Modulation, Dysbiosis, and Dermatological Implications.Molecules (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Centella asiatica extract (CAE) and Marigold extract (ME) have been renowned for centuries in traditional medicine, particularly in Asia, for their wound-healing, anti-inflammatory and skin-regenerative properties. This study presents the formulation and comprehensive evaluation of serums enhanced with these extracts, aiming to harness their bioactive properties for skin health. Serums were selected over creams due to their lightweight, water-based nature, which ensures faster absorption and enhanced skin penetration of active ingredients. The serums, developed in varying concentrations (0.2%, 0.5% and 1.0%), were assessed for physicochemical properties, stability, bioactivity and skin barrier enhancement. Stability tests confirmed the serums' robustness, maintaining consistent pH (5.0-6.5), viscosity and organoleptic properties over 60 days. The MTT assay revealed that both extracts were non-cytotoxic, maintaining cell viability above 100%, with formulations containing CAE, demonstrating a concentration-dependent proliferative effect, reaching nearly 120%. Antibacterial evaluation using the agar well diffusion assay showed that both extracts exhibited considerable activity, with CAE achieving greater inhibition zones, particularly against S. aureus. Antioxidant, anti-inflammatory and anti-tyrosinase activities confirmed the strong bioactive potential of both extracts in combating oxidative stress, reducing inflammation, and regulating pigmentation. Skin barrier and permeability studies demonstrated the serums' ability to improve barrier integrity and facilitate active compound delivery. These findings demonstrate the potential of Centella asiatica and Marigold extracts for multifunctional skincare formulations, combining regeneration, hydration, antioxidant and antibacterial benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.